GEn1E Lifesciences
GEn1E Lifesciences, based in Palo Alto, CA, is a healthcare company specializing in therapeutics, utilizing an AI/ML platform named RIDGE™ to enhance drug development from discovery through clinical studies.
Company Overview of GEn1E Lifesciences
GEn1E Lifesciences, previously known as Gen1E Lifesciences Inc., is headquartered in Palo Alto, California. Operating in the healthcare industry, specifically within therapeutics, the company utilizes advanced AI/ML platforms to streamline drug development processes. Their technologies include neural networks, gradient boosting methods, and hidden Markov models, which have significantly accelerated their development timelines.
AI/ML Drug Development Platform
GEn1E Lifesciences employs an AI/ML platform named RIDGE™ that spans the entire process from drug discovery through to clinical studies. This platform is integral in accelerating drug development by efficiently mapping diseases to identify additional indications, thereby broadening the scope of potential treatments. Technologies utilized include neural networks, gradient boosting methods, and hidden Markov models.
Therapeutic Pipeline and Development
GEn1E Lifesciences has developed a robust pipeline targeting multiple therapeutic areas. The company boasts 21 first-in-class compounds, with one asset currently in Phase 2 and three preclinical programs underway. Their efficient drug development model has allowed the company to accelerate a lead compound from early discovery to Phase 2 in just 2.5 years utilizing seed capital.
Partnerships and Collaborations
GEn1E Lifesciences collaborates with key partners such as Vituity, BARDA, and Inflect Health. These partnerships are crucial in supporting the company's mission of developing advanced therapeutic solutions efficiently. Their collaborations enhance GEn1E’s capabilities in both discovery and clinical studies phases.
Recognition and Awards
GEn1E Lifesciences has been acknowledged for its innovative contributions to healthcare. The company was awarded the UCSF Health Hub Digital Health Award, underscoring their impactful work in the field of digital health and therapeutic developments.